Ansell (Ansell) 3-Year EBITDA Growth Rate

: 4.10% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

Ansell's EBITDA per Share for the six months ended in Dec. 2023 was $0.60.

During the past 12 months, Ansell's average EBITDA Per Share Growth Rate was -15.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 4.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ansell was 30.20% per year. The lowest was -29.80% per year. And the median was 4.10% per year.

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Ansell's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ansell 3-Year EBITDA Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ansell's 3-Year EBITDA Growth Rate falls into.

Ansell 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Ansell (OTCPK:ANSLF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Ansell 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Ansell's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ansell (Ansell) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ANSLY:USA PD1A:Germany ANN:Australia

Address

678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121

Website

https://www.ansell.com

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell (Ansell) Headlines

From GuruFocus

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA • 05-19-2021

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA • 02-15-2017

Ansell Growing Through M&A

By Holmes Osborne, CFA Holmes Osborne, CFA • 02-22-2019